Qiuping Xiang
7PUBLICATIONS
11CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (7)
Sort by Publication Date:
|Feb 17, 2026
Discovery of ZX079 as a Dual PROTAC Degrader Targeting BRD4/CBP in Acute Myeloid Leukemia.Qiuping Xiang, Yanan Wang, Mengli Gu
|Aug 05, 2025
Discovery of Potent Dual PROTAC Degraders Targeting BET-Kinase To Overcome FLT3 Inhibitor Resistance.Qiuping Xiang, Yujie Sun, Hui Hua
|Jun 20, 2025
Discovery of a Potent, Selective, and Multiple His435 Mutation-Sensitive Thyroid Hormone Receptor β Agonist.Qiu Li, Benqiang Yao, Shiting Zhao
|Jan 02, 2025
Discovery of HZS60 as a Novel Brain Penetrant NMDAR/TRPM4 Interaction Interface Inhibitor with Improved Activity and Pharmacokinetic Properties for the Treatment of Cerebral Ischemia.Meiling Sun, Lin Wang, Qiaofeng Cao
|Nov 27, 2024
Discovery of the First BRD4 Second Bromodomain (BD2)-Selective Inhibitors.Junhua Li, Qingqing Hu, Run Zhu
|Jun 03, 2024
Discovery of a Promising CBP/p300 Degrader XYD129 for the Treatment of Acute Myeloid Leukemia.Tianbang Wu, Jiankang Hu, Xiaofan Zhao
Pageof 2
